Video

Another Olympic Athlete Suspended For Doping — Prescription Asthma Medication

REUTERS/Kim Kyung-Hoon

Daily Caller News Foundation logo
Font Size:

Another Olympian was suspended for doping after testing positive for Fenoterol in his asthma medication Tuesday.

Slovenian ice-skater Ziga Jeglic, 29, was pulled from the Pyeongchang Winter Olympics due to the banned Fenoterol (a drug that opens airways in the lungs), which his doctor prescribed for asthma medication, The Court of Arbitration for Sport said, according to the New York Post.

“Ziga Jeglic (Ice Hockey, Slovenia), positive in-competition test with fenoterol (beta-2 agonist; specified substance); the athlete accepted an anti-doping rule violation and, as a consequence, the athlete is suspended from competing in the remainder of the Olympic Winter Games Pyeongchang 2018,” the International Ice Hockey Federation said in a statement on their website.

Jeglic issued an official response to his suspension: “I have overlooked the difference between comparable drugs, which are allowed and would enable me to use it for my respiratory problems during the Olympics,” he said. “I apologize for my negligence to all the persons involved, and I accept the further anti-doping procedures.”

Slovenia previously beat Slovakia 3-2, with Jeglic scoring the winning goal Saturday.

Follow Gabrielle on Twitter
Send tips to gabrielle@dailycallernewsfoundation.org.

Freedom of Speech Isn’t Free
The Daily Caller News Foundation is working hard to balance out the biased American media. For as little as $3, you can help us. Make a one-time donation to support the quality, independent journalism of TheDCNF. We’re not dependent on commercial or political support and we do not accept any government funding.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.